Merck & Co., Inc. Organon & Co. (OGN) insider trading activity

OGN Quotes by TradingView

Merck & Co., Inc. is > 10% Shareholder of Organon & Co.. Currently has a direct ownership of 0 shares of OGN, which is worth approximately $0. The most recent transaction as insider was on Jun 02, 2021, when has been sold 253,516,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Merck & Co., Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2021
SELL
Other acquisition or disposition
-
253,516,000 Reduced 100.0%
0 Common Stock

Also insider at

BGNE
BeiGene, Ltd. Healthcare
> 10% Shareholder
OPGN
OPGEN INC Healthcare
> 10% Shareholder
STRO
SUTRO BIOPHARMA, INC. Healthcare
> 10% Shareholder
NGM
NGM BIOPHARMACEUTICALS INC Healthcare
> 10% Shareholder
HARP
Harpoon Therapeutics, Inc. Healthcare
M&C

Merck & Co., Inc.

> 10% Shareholder
Kenilworth, NJ

Track Institutional and Insider Activities on OGN

Follow Organon & Co. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OGN shares.

Notify only if

Insider Trading

Get notified when an Organon & Co. insider buys or sells OGN shares.

Notify only if

News

Receive news related to Organon & Co.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OGN